Drug Therapy, Combination
"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy with two or more separate preparations given for a combined effect.
| Descriptor ID |
D004359
|
| MeSH Number(s) |
E02.319.310
|
| Concept/Terms |
Drug Therapy, Combination- Drug Therapy, Combination
- Combination Chemotherapy
- Drug Polytherapy
- Drug Polytherapies
- Polytherapies, Drug
- Polytherapy, Drug
- Therapy, Combination Drug
- Chemotherapy, Combination
- Chemotherapies, Combination
- Combination Chemotherapies
- Combination Drug Therapy
- Combination Drug Therapies
- Drug Therapies, Combination
- Therapies, Combination Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".
Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 13 | 13 |
| 1996 | 0 | 18 | 18 |
| 1997 | 1 | 16 | 17 |
| 1998 | 2 | 14 | 16 |
| 1999 | 1 | 11 | 12 |
| 2000 | 1 | 14 | 15 |
| 2001 | 0 | 14 | 14 |
| 2002 | 1 | 18 | 19 |
| 2003 | 4 | 37 | 41 |
| 2004 | 3 | 29 | 32 |
| 2005 | 0 | 24 | 24 |
| 2006 | 0 | 28 | 28 |
| 2007 | 0 | 26 | 26 |
| 2008 | 0 | 33 | 33 |
| 2009 | 0 | 43 | 43 |
| 2010 | 0 | 32 | 32 |
| 2011 | 2 | 43 | 45 |
| 2012 | 2 | 39 | 41 |
| 2013 | 1 | 33 | 34 |
| 2014 | 0 | 37 | 37 |
| 2015 | 1 | 36 | 37 |
| 2016 | 0 | 35 | 35 |
| 2017 | 0 | 39 | 39 |
| 2018 | 4 | 42 | 46 |
| 2019 | 1 | 37 | 38 |
| 2020 | 1 | 37 | 38 |
| 2021 | 0 | 16 | 16 |
| 2022 | 1 | 10 | 11 |
| 2023 | 1 | 16 | 17 |
| 2024 | 3 | 19 | 22 |
| 2025 | 0 | 16 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
-
Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial. Blood Adv. 2025 Aug 12; 9(15):3728-3738.
-
Rationale and design of the REMBRANDT trial: A phase 3 study to evaluate the effect of obicetrapib/ezetimibe on coronary plaque characteristics. Am Heart J. 2025 Dec; 290:325-338.
-
Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD). J Affect Disord. 2025 Dec 01; 390:119836.
-
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20?years in sub-Saharan Africa. Contemp Clin Trials. 2025 Aug; 155:107963.
-
Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin? Cardiol J. 2025; 32(3):321-327.
-
Effect of initial combination therapy vs. step-therapy on adherence and persistence in drug na?ve type 2 diabetes patients. J Diabetes Complications. 2025 Sep; 39(9):109080.
-
The effect of adjunctive cariprazine on symptoms of anhedonia in patients with major depressive disorder. J Affect Disord. 2025 Sep 15; 385:119366.
-
Group-based trajectory modeling to identify longitudinal patterns and predictors of adherence among older adults on concomitant triple therapy (oral antidiabetic, renin-angiotensin-system antagonists, statins). J Manag Care Spec Pharm. 2025 Apr; 31(4):396-405.
-
Long-term efficacy and safety of sofosbuvir-based direct-acting antiviral regimens in paediatric patients with hepatitis C virus infection: an international registry study. Lancet Child Adolesc Health. 2025 04; 9(4):248-254.
-
Impact of an Electronic Medical Record Quality Improvement Intervention on Helicobacter pylori Treatment and Eradication Rates in a U.S. Hospital System. Helicobacter. 2025 Mar-Apr; 30(2):e70034.